ECSP20016817A - Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda - Google Patents

Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda

Info

Publication number
ECSP20016817A
ECSP20016817A ECSENADI202016817A ECDI202016817A ECSP20016817A EC SP20016817 A ECSP20016817 A EC SP20016817A EC SENADI202016817 A ECSENADI202016817 A EC SENADI202016817A EC DI202016817 A ECDI202016817 A EC DI202016817A EC SP20016817 A ECSP20016817 A EC SP20016817A
Authority
EC
Ecuador
Prior art keywords
systems
methods
control
necrosis disease
hepatopancreatic necrosis
Prior art date
Application number
ECSENADI202016817A
Other languages
English (en)
Inventor
Elena Sineva
Sayre Richard
Tatiana Vinogradova-Shah
Original Assignee
Pebble Labs Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2018/025766 external-priority patent/WO2018184029A1/en
Priority claimed from PCT/US2018/033976 external-priority patent/WO2018217819A1/en
Application filed by Pebble Labs Usa Inc filed Critical Pebble Labs Usa Inc
Publication of ECSP20016817A publication Critical patent/ECSP20016817A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/60—Isolated nucleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Virology (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)

Abstract

En general, la tecnología de la invención se refiere a novedosas estrategias para el control de enfermedades en sistemas animales. Específicamente, la tecnología de la invención se refiere a métodos, sistemas y composiciones novedosas para el biocontrol de patógenos en sistemas acuáticos. Específicamente, la invención puede comprender técnicas, sistemas y métodos novedosos para el biocontrol de patógenos transmisores de enfermedades que afectan a los camarones en los sistemas acuícolas.
ECSENADI202016817A 2017-08-07 2020-03-06 Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda ECSP20016817A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762541824P 2017-08-07 2017-08-07
PCT/US2018/025766 WO2018184029A1 (en) 2017-03-31 2018-04-02 Novel system for the biocontrol of pathogens in aquaculture and other animal systems
PCT/US2018/033976 WO2018217819A1 (en) 2017-05-22 2018-05-22 Transbiotic regulation of bacterial gene expression

Publications (1)

Publication Number Publication Date
ECSP20016817A true ECSP20016817A (es) 2020-04-22

Family

ID=65271567

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202016817A ECSP20016817A (es) 2017-08-07 2020-03-06 Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda

Country Status (9)

Country Link
US (1) US11944676B2 (es)
EP (1) EP3664616A4 (es)
CN (1) CN111433349A (es)
BR (1) BR112020002689A2 (es)
CL (1) CL2020000329A1 (es)
EC (1) ECSP20016817A (es)
MX (1) MX2020001574A (es)
SG (1) SG11202001143YA (es)
WO (1) WO2019032629A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019032629A1 (en) 2017-08-07 2019-02-14 Pebble Labs Inc. SYSTEMS AND METHODS FOR FIGHTING ACUTE HEEPATOPANCREATIC NECROSIS DISEASE
CN110317792B (zh) * 2019-06-03 2021-05-25 台州学院 副溶血弧菌噬菌体vp-hyp2及其应用
CN114980750A (zh) * 2019-09-05 2022-08-30 美国卵石实验室公司 用于抑制细菌毒素以治疗水生动物早期死亡综合征的系统、方法和组合物
US20230233621A1 (en) * 2020-06-12 2023-07-27 Pebble Labs Inc. Novel probiotic bacteria and methods to control pathogens in aquatic animals
CN112753629B (zh) * 2020-12-30 2022-08-30 亚太海洋生物科技(厦门)有限公司 南美白对虾养殖前期去除急性肝胰腺坏死病毒的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294533A (en) 1988-07-05 1994-03-15 Baylor College Of Medicine Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
WO2003064592A2 (en) * 2001-10-26 2003-08-07 Quorex Pharmaceuticals, Inc. Inhibitors of autoinducer transporters
US20050227933A1 (en) 2001-11-29 2005-10-13 Benkovic Stephen J Treatment of bacterial induced diseases using DNA methyl transferase inhibitors
JP5183064B2 (ja) * 2003-07-02 2013-04-17 エムユーエスシー ファウンデイション フォー リサーチ デべロップメント 甲殻類動物、及び他の無脊椎動物における、ｄｓＲＮＡで誘導された特異的、及び非特異的免疫、及びそこで使用する生物送達媒体
US7247437B2 (en) 2003-08-21 2007-07-24 Trustees Of Tufts College Vibrionaceae replication factors and methods of use thereof
US20050158326A1 (en) 2003-12-24 2005-07-21 Chin-Yu Chen Compositions for reducing virus infection rate in aquatic crustaceans and applications thereof
US20080194504A1 (en) 2004-02-06 2008-08-14 Advanced Bionutrition Corporation Rna-Mediated Interference to Control Disease in Terrestrial and Aquaculture Animals
US20080107652A1 (en) * 2006-08-25 2008-05-08 Science & Technology Corporation @ University Of New Mexico Stc.Unm Methods and compositions for control of disease in aquaculture
DK2754354T3 (en) 2008-09-17 2016-03-21 Bayer Cropscience Lp A method of using a Bacillus subtilis strain to improve the animal health
EP2633049B1 (en) 2010-10-27 2018-10-10 Harrisvaccines Inc Methods and compositions to protect aquatic invertebrates from disease
KR101242821B1 (ko) * 2011-01-31 2013-03-12 씨제이제일제당 (주) 비브리오 속 미생물에 대한 생물학적 방제용 프로바이오틱스
KR101049672B1 (ko) 2011-02-01 2011-07-14 박명진 초음파 유도하 중재적 시술용 바늘구조
GB201107768D0 (en) * 2011-05-10 2011-06-22 Univ Manchester Riboswitches
US9932598B2 (en) 2012-08-02 2018-04-03 The Regents Of The University Of California Metabolic engineering of microbial organisms
US9445603B2 (en) 2013-03-15 2016-09-20 Monsanto Technology Llc Compositions and methods for the production and delivery of double stranded RNA
WO2015059690A1 (en) * 2013-10-24 2015-04-30 Yeda Research And Development Co. Ltd. Polynucleotides encoding brex system polypeptides and methods of using s ame
MX2016004039A (es) * 2013-11-04 2016-06-02 Aardvark Ip Holding Llc Sistemas y metodos de tratamiento de agua para acuicultura.
WO2018053451A1 (en) 2016-09-16 2018-03-22 Pebble Labs Novel paratransgenic system for the biocontrol of disease-transmitting mosquitos
AU2018243858A1 (en) 2017-03-31 2019-10-10 Pebble Labs Usa Inc. Novel system for the biocontrol of pathogens in aquaculture and other animal systems
CN111465323A (zh) 2017-05-22 2020-07-28 美国卵石实验室公司 细菌基因表达的跨生物调节
WO2019032629A1 (en) 2017-08-07 2019-02-14 Pebble Labs Inc. SYSTEMS AND METHODS FOR FIGHTING ACUTE HEEPATOPANCREATIC NECROSIS DISEASE

Also Published As

Publication number Publication date
US20200178566A1 (en) 2020-06-11
EP3664616A1 (en) 2020-06-17
MX2020001574A (es) 2020-09-03
BR112020002689A2 (pt) 2020-08-25
CN111433349A (zh) 2020-07-17
CL2020000329A1 (es) 2020-08-14
EP3664616A4 (en) 2021-08-11
SG11202001143YA (en) 2020-03-30
WO2019032629A1 (en) 2019-02-14
US11944676B2 (en) 2024-04-02

Similar Documents

Publication Publication Date Title
ECSP20016817A (es) Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda
ECSP20046463A (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas
MX382230B (es) Composiciones y metodos para modular la expresion de similar a la angiopoyetina tipo 3.
CL2018000052A1 (es) Heterociclos nitrogenados como pesticidas.
BR112017005388A2 (pt) método para criar animais.
JOP20200231B1 (ar) ناهضات ppar (مستقبل ناشر بيروكسيزوم منشط)، ومركبات، ومكونات أدوية، وطرق استعمالها
BR112019000693A2 (pt) composições de muc1- car e métodos para uso
MX391988B (es) Sistema novedoso para el biocontrol de patógenos en sistemas de acuicultura y otros sistemas animales.
CR11810A (es) Compuestos de 1,2-benzotiazolo utiles para combatir plagas animales
BR112013005136A2 (pt) composições e métodos para controlar pragas de nematodeo
CL2018002645A1 (es) Sulfonamidas sustituidas para controlar plagas animales
MX384427B (es) Composiciones de proteína concentrada y métodos para su elaboración y uso.
AR111837A1 (es) Plantas transgénicas inmunomoduladoras y métodos relacionados
MX2018012538A (es) Agonistas del receptor activado por proliferador de peroxisoma (ppar), compuestos, composiciones farmaceuticas y metodos para usar los mismos.
EA201891342A1 (ru) Изоиндольные соединения
CL2020003168A1 (es) Métodos de uso de cd24 para prevenir y tratar la enfermedad de injerto contra huésped y la mucositis
CL2018003037A1 (es) 2-alquilimidazolilcarboxamidas sustituidas como plaguicidas.
CL2021001689A1 (es) Ácido r-piridiloxicarboxílico y sal, derivado del éster, método de preparación, composición herbicida y aplicación del mismo.
CL2017002931A1 (es) Método para incrementar la utilización de proteína de soja por peces salmónidos.
BR112021020349A2 (pt) Peixe estéril
UY37979A (es) Sistema de cosecha subacuática mejorado
BR112017017974A2 (pt) método para a fabricação de uma ração, método não terapêutico, ração em gel não estruturada e composição de base de pectina
ECSP20019404A (es) Agentes microbianos para alimentación directa para mejorar el estado general y salud de los peces
CL2018001084A1 (es) Dieta artificial para la crianza de rhyzobius lophanthae, familia coccinellidae, enemigo natural de escamas (coccoidea), método de preparación de la dieta.
UA41439S (uk) М'ясорубка